Pharma & Healthcare
Global Heart Failure Drugs Market Research Report 2025
- Apr 16, 25
- ID: 195846
- Pages: 88
- Figures: 95
- Views: 1
The global market for Heart Failure Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Heart failure occurs when your heart muscle doesn"t pump blood as well as it should.
The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption place in the Turkey and Middle East & Africa market, with a consumption market share nearly 21%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heart Failure Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Failure Drugs.
The Heart Failure Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heart Failure Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heart Failure Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Segment by Type
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Segment by Application
Reduced Ejection Fraction
Preserved Ejection Fraction
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heart Failure Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heart Failure Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Heart failure occurs when your heart muscle doesn"t pump blood as well as it should.
The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption place in the Turkey and Middle East & Africa market, with a consumption market share nearly 21%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heart Failure Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Failure Drugs.
The Heart Failure Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heart Failure Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heart Failure Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Segment by Type
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Segment by Application
Reduced Ejection Fraction
Preserved Ejection Fraction
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heart Failure Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heart Failure Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Heart Failure Drugs Market Overview
1.1 Product Definition
1.2 Heart Failure Drugs by Type
1.2.1 Global Heart Failure Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Heart Failure Drugs by Application
1.3.1 Global Heart Failure Drugs Market Value by Application (2024 VS 2031)
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Global Heart Failure Drugs Market Size Estimates and Forecasts
1.4.1 Global Heart Failure Drugs Revenue 2020-2031
1.4.2 Global Heart Failure Drugs Sales 2020-2031
1.4.3 Global Heart Failure Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Heart Failure Drugs Market Competition by Manufacturers
2.1 Global Heart Failure Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Heart Failure Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Heart Failure Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Heart Failure Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heart Failure Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heart Failure Drugs, Product Type & Application
2.7 Global Key Manufacturers of Heart Failure Drugs, Date of Enter into This Industry
2.8 Global Heart Failure Drugs Market Competitive Situation and Trends
2.8.1 Global Heart Failure Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Heart Failure Drugs Players Market Share by Revenue
2.8.3 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Heart Failure Drugs Market Scenario by Region
3.1 Global Heart Failure Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Heart Failure Drugs Sales by Region: 2020-2031
3.2.1 Global Heart Failure Drugs Sales by Region: 2020-2025
3.2.2 Global Heart Failure Drugs Sales by Region: 2026-2031
3.3 Global Heart Failure Drugs Revenue by Region: 2020-2031
3.3.1 Global Heart Failure Drugs Revenue by Region: 2020-2025
3.3.2 Global Heart Failure Drugs Revenue by Region: 2026-2031
3.4 North America Heart Failure Drugs Market Facts & Figures by Country
3.4.1 North America Heart Failure Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Heart Failure Drugs Sales by Country (2020-2031)
3.4.3 North America Heart Failure Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heart Failure Drugs Market Facts & Figures by Country
3.5.1 Europe Heart Failure Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Heart Failure Drugs Sales by Country (2020-2031)
3.5.3 Europe Heart Failure Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heart Failure Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Heart Failure Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Heart Failure Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Heart Failure Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heart Failure Drugs Market Facts & Figures by Country
3.7.1 Latin America Heart Failure Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Heart Failure Drugs Sales by Country (2020-2031)
3.7.3 Latin America Heart Failure Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heart Failure Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Heart Failure Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Heart Failure Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Heart Failure Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heart Failure Drugs Sales by Type (2020-2031)
4.1.1 Global Heart Failure Drugs Sales by Type (2020-2025)
4.1.2 Global Heart Failure Drugs Sales by Type (2026-2031)
4.1.3 Global Heart Failure Drugs Sales Market Share by Type (2020-2031)
4.2 Global Heart Failure Drugs Revenue by Type (2020-2031)
4.2.1 Global Heart Failure Drugs Revenue by Type (2020-2025)
4.2.2 Global Heart Failure Drugs Revenue by Type (2026-2031)
4.2.3 Global Heart Failure Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Heart Failure Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Heart Failure Drugs Sales by Application (2020-2031)
5.1.1 Global Heart Failure Drugs Sales by Application (2020-2025)
5.1.2 Global Heart Failure Drugs Sales by Application (2026-2031)
5.1.3 Global Heart Failure Drugs Sales Market Share by Application (2020-2031)
5.2 Global Heart Failure Drugs Revenue by Application (2020-2031)
5.2.1 Global Heart Failure Drugs Revenue by Application (2020-2025)
5.2.2 Global Heart Failure Drugs Revenue by Application (2026-2031)
5.2.3 Global Heart Failure Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Heart Failure Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Heart Failure Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Heart Failure Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Heart Failure Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Hikma
6.4.1 Hikma Company Information
6.4.2 Hikma Description and Business Overview
6.4.3 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hikma Heart Failure Drugs Product Portfolio
6.4.5 Hikma Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Heart Failure Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cipla Heart Failure Drugs Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Merck & Co.
6.7.1 Merck & Co. Company Information
6.7.2 Merck & Co. Description and Business Overview
6.7.3 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck & Co. Heart Failure Drugs Product Portfolio
6.7.5 Merck & Co. Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Company Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Amgen Heart Failure Drugs Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 Roche
6.9.1 Roche Company Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Roche Heart Failure Drugs Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Sun Pharma
6.10.1 Sun Pharma Company Information
6.10.2 Sun Pharma Description and Business Overview
6.10.3 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sun Pharma Heart Failure Drugs Product Portfolio
6.10.5 Sun Pharma Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Company Information
6.11.2 Mylan Description and Business Overview
6.11.3 Mylan Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mylan Heart Failure Drugs Product Portfolio
6.11.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heart Failure Drugs Industry Chain Analysis
7.2 Heart Failure Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heart Failure Drugs Production Mode & Process Analysis
7.4 Heart Failure Drugs Sales and Marketing
7.4.1 Heart Failure Drugs Sales Channels
7.4.2 Heart Failure Drugs Distributors
7.5 Heart Failure Drugs Customer Analysis
8 Heart Failure Drugs Market Dynamics
8.1 Heart Failure Drugs Industry Trends
8.2 Heart Failure Drugs Market Drivers
8.3 Heart Failure Drugs Market Challenges
8.4 Heart Failure Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Heart Failure Drugs by Type
1.2.1 Global Heart Failure Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Heart Failure Drugs by Application
1.3.1 Global Heart Failure Drugs Market Value by Application (2024 VS 2031)
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Global Heart Failure Drugs Market Size Estimates and Forecasts
1.4.1 Global Heart Failure Drugs Revenue 2020-2031
1.4.2 Global Heart Failure Drugs Sales 2020-2031
1.4.3 Global Heart Failure Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Heart Failure Drugs Market Competition by Manufacturers
2.1 Global Heart Failure Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Heart Failure Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Heart Failure Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Heart Failure Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heart Failure Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heart Failure Drugs, Product Type & Application
2.7 Global Key Manufacturers of Heart Failure Drugs, Date of Enter into This Industry
2.8 Global Heart Failure Drugs Market Competitive Situation and Trends
2.8.1 Global Heart Failure Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Heart Failure Drugs Players Market Share by Revenue
2.8.3 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Heart Failure Drugs Market Scenario by Region
3.1 Global Heart Failure Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Heart Failure Drugs Sales by Region: 2020-2031
3.2.1 Global Heart Failure Drugs Sales by Region: 2020-2025
3.2.2 Global Heart Failure Drugs Sales by Region: 2026-2031
3.3 Global Heart Failure Drugs Revenue by Region: 2020-2031
3.3.1 Global Heart Failure Drugs Revenue by Region: 2020-2025
3.3.2 Global Heart Failure Drugs Revenue by Region: 2026-2031
3.4 North America Heart Failure Drugs Market Facts & Figures by Country
3.4.1 North America Heart Failure Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Heart Failure Drugs Sales by Country (2020-2031)
3.4.3 North America Heart Failure Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heart Failure Drugs Market Facts & Figures by Country
3.5.1 Europe Heart Failure Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Heart Failure Drugs Sales by Country (2020-2031)
3.5.3 Europe Heart Failure Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heart Failure Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Heart Failure Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Heart Failure Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Heart Failure Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heart Failure Drugs Market Facts & Figures by Country
3.7.1 Latin America Heart Failure Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Heart Failure Drugs Sales by Country (2020-2031)
3.7.3 Latin America Heart Failure Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heart Failure Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Heart Failure Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Heart Failure Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Heart Failure Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heart Failure Drugs Sales by Type (2020-2031)
4.1.1 Global Heart Failure Drugs Sales by Type (2020-2025)
4.1.2 Global Heart Failure Drugs Sales by Type (2026-2031)
4.1.3 Global Heart Failure Drugs Sales Market Share by Type (2020-2031)
4.2 Global Heart Failure Drugs Revenue by Type (2020-2031)
4.2.1 Global Heart Failure Drugs Revenue by Type (2020-2025)
4.2.2 Global Heart Failure Drugs Revenue by Type (2026-2031)
4.2.3 Global Heart Failure Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Heart Failure Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Heart Failure Drugs Sales by Application (2020-2031)
5.1.1 Global Heart Failure Drugs Sales by Application (2020-2025)
5.1.2 Global Heart Failure Drugs Sales by Application (2026-2031)
5.1.3 Global Heart Failure Drugs Sales Market Share by Application (2020-2031)
5.2 Global Heart Failure Drugs Revenue by Application (2020-2031)
5.2.1 Global Heart Failure Drugs Revenue by Application (2020-2025)
5.2.2 Global Heart Failure Drugs Revenue by Application (2026-2031)
5.2.3 Global Heart Failure Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Heart Failure Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Heart Failure Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Heart Failure Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Heart Failure Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Hikma
6.4.1 Hikma Company Information
6.4.2 Hikma Description and Business Overview
6.4.3 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hikma Heart Failure Drugs Product Portfolio
6.4.5 Hikma Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Heart Failure Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cipla Heart Failure Drugs Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Merck & Co.
6.7.1 Merck & Co. Company Information
6.7.2 Merck & Co. Description and Business Overview
6.7.3 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck & Co. Heart Failure Drugs Product Portfolio
6.7.5 Merck & Co. Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Company Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Amgen Heart Failure Drugs Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 Roche
6.9.1 Roche Company Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Roche Heart Failure Drugs Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Sun Pharma
6.10.1 Sun Pharma Company Information
6.10.2 Sun Pharma Description and Business Overview
6.10.3 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sun Pharma Heart Failure Drugs Product Portfolio
6.10.5 Sun Pharma Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Company Information
6.11.2 Mylan Description and Business Overview
6.11.3 Mylan Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mylan Heart Failure Drugs Product Portfolio
6.11.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heart Failure Drugs Industry Chain Analysis
7.2 Heart Failure Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heart Failure Drugs Production Mode & Process Analysis
7.4 Heart Failure Drugs Sales and Marketing
7.4.1 Heart Failure Drugs Sales Channels
7.4.2 Heart Failure Drugs Distributors
7.5 Heart Failure Drugs Customer Analysis
8 Heart Failure Drugs Market Dynamics
8.1 Heart Failure Drugs Industry Trends
8.2 Heart Failure Drugs Market Drivers
8.3 Heart Failure Drugs Market Challenges
8.4 Heart Failure Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Heart Failure Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Heart Failure Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Heart Failure Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Heart Failure Drugs Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Heart Failure Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Heart Failure Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Heart Failure Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Heart Failure Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Heart Failure Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Heart Failure Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Heart Failure Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Heart Failure Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Heart Failure Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Heart Failure Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Heart Failure Drugs Sales by Region (2020-2025) & (MT)
Table 18. Global Heart Failure Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Heart Failure Drugs Sales by Region (2026-2031) & (MT)
Table 20. Global Heart Failure Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Heart Failure Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Heart Failure Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Heart Failure Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Heart Failure Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Heart Failure Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 27. North America Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 28. North America Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Heart Failure Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 32. Europe Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 33. Europe Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Heart Failure Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Heart Failure Drugs Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Heart Failure Drugs Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Heart Failure Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Heart Failure Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Heart Failure Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 42. Latin America Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 43. Latin America Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Heart Failure Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Heart Failure Drugs Sales (MT) by Type (2020-2025)
Table 51. Global Heart Failure Drugs Sales (MT) by Type (2026-2031)
Table 52. Global Heart Failure Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Heart Failure Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Heart Failure Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Heart Failure Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Heart Failure Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Heart Failure Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Heart Failure Drugs Price (USD/MT) by Type (2020-2025)
Table 59. Global Heart Failure Drugs Price (USD/MT) by Type (2026-2031)
Table 60. Global Heart Failure Drugs Sales (MT) by Application (2020-2025)
Table 61. Global Heart Failure Drugs Sales (MT) by Application (2026-2031)
Table 62. Global Heart Failure Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Heart Failure Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Heart Failure Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Heart Failure Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Heart Failure Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Heart Failure Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Heart Failure Drugs Price (USD/MT) by Application (2020-2025)
Table 69. Global Heart Failure Drugs Price (USD/MT) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. Novartis Heart Failure Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Pfizer Heart Failure Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. AstraZeneca Heart Failure Drugs Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Hikma Company Information
Table 86. Hikma Description and Business Overview
Table 87. Hikma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Hikma Heart Failure Drugs Product
Table 89. Hikma Recent Developments/Updates
Table 90. Teva Company Information
Table 91. Teva Description and Business Overview
Table 92. Teva Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Teva Heart Failure Drugs Product
Table 94. Teva Recent Developments/Updates
Table 95. Cipla Company Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Cipla Heart Failure Drugs Product
Table 99. Cipla Recent Developments/Updates
Table 100. Merck & Co. Company Information
Table 101. Merck & Co. Description and Business Overview
Table 102. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Merck & Co. Heart Failure Drugs Product
Table 104. Merck & Co. Recent Developments/Updates
Table 105. Amgen Company Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Amgen Heart Failure Drugs Product
Table 109. Amgen Recent Developments/Updates
Table 110. Roche Company Information
Table 111. Roche Description and Business Overview
Table 112. Roche Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Roche Heart Failure Drugs Product
Table 114. Roche Recent Developments/Updates
Table 115. Sun Pharma Company Information
Table 116. Sun Pharma Description and Business Overview
Table 117. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Sun Pharma Heart Failure Drugs Product
Table 119. Sun Pharma Recent Developments/Updates
Table 120. Mylan Company Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Mylan Heart Failure Drugs Product
Table 124. Mylan Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Heart Failure Drugs Distributors List
Table 128. Heart Failure Drugs Customers List
Table 129. Heart Failure Drugs Market Trends
Table 130. Heart Failure Drugs Market Drivers
Table 131. Heart Failure Drugs Market Challenges
Table 132. Heart Failure Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Heart Failure Drugs
Figure 2. Global Heart Failure Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Heart Failure Drugs Market Share by Type: 2024 & 2031
Figure 4. ACEI Product Picture
Figure 5. Angiotensin II Receptor Blockers Product Picture
Figure 6. ARNIs Product Picture
Figure 7. Beta Blockers Product Picture
Figure 8. Aldosterone Antagonists Product Picture
Figure 9. Diuretics Product Picture
Figure 10. Global Heart Failure Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Heart Failure Drugs Market Share by Application: 2024 & 2031
Figure 12. Reduced Ejection Fraction
Figure 13. Preserved Ejection Fraction
Figure 14. Global Heart Failure Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Heart Failure Drugs Market Size (2020-2031) & (US$ Million)
Figure 16. Global Heart Failure Drugs Sales (2020-2031) & (MT)
Figure 17. Global Heart Failure Drugs Average Price (USD/MT) & (2020-2031)
Figure 18. Heart Failure Drugs Report Years Considered
Figure 19. Heart Failure Drugs Sales Share by Manufacturers in 2024
Figure 20. Global Heart Failure Drugs Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Heart Failure Drugs Players: Market Share by Revenue in Heart Failure Drugs in 2024
Figure 22. Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Heart Failure Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 25. North America Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 29. Europe Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Heart Failure Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Heart Failure Drugs Revenue Market Share by Region (2020-2031)
Figure 37. China Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Taiwan Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 48. Latin America Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Heart Failure Drugs by Type (2020-2031)
Figure 58. Global Revenue Market Share of Heart Failure Drugs by Type (2020-2031)
Figure 59. Global Heart Failure Drugs Price (USD/MT) by Type (2020-2031)
Figure 60. Global Sales Market Share of Heart Failure Drugs by Application (2020-2031)
Figure 61. Global Revenue Market Share of Heart Failure Drugs by Application (2020-2031)
Figure 62. Global Heart Failure Drugs Price (USD/MT) by Application (2020-2031)
Figure 63. Heart Failure Drugs Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Heart Failure Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Heart Failure Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Heart Failure Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Heart Failure Drugs Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Heart Failure Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Heart Failure Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Heart Failure Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Heart Failure Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Heart Failure Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Heart Failure Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Heart Failure Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Heart Failure Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Heart Failure Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Heart Failure Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Heart Failure Drugs Sales by Region (2020-2025) & (MT)
Table 18. Global Heart Failure Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Heart Failure Drugs Sales by Region (2026-2031) & (MT)
Table 20. Global Heart Failure Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Heart Failure Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Heart Failure Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Heart Failure Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Heart Failure Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Heart Failure Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 27. North America Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 28. North America Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Heart Failure Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 32. Europe Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 33. Europe Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Heart Failure Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Heart Failure Drugs Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Heart Failure Drugs Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Heart Failure Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Heart Failure Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Heart Failure Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 42. Latin America Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 43. Latin America Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Heart Failure Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Heart Failure Drugs Sales (MT) by Type (2020-2025)
Table 51. Global Heart Failure Drugs Sales (MT) by Type (2026-2031)
Table 52. Global Heart Failure Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Heart Failure Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Heart Failure Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Heart Failure Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Heart Failure Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Heart Failure Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Heart Failure Drugs Price (USD/MT) by Type (2020-2025)
Table 59. Global Heart Failure Drugs Price (USD/MT) by Type (2026-2031)
Table 60. Global Heart Failure Drugs Sales (MT) by Application (2020-2025)
Table 61. Global Heart Failure Drugs Sales (MT) by Application (2026-2031)
Table 62. Global Heart Failure Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Heart Failure Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Heart Failure Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Heart Failure Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Heart Failure Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Heart Failure Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Heart Failure Drugs Price (USD/MT) by Application (2020-2025)
Table 69. Global Heart Failure Drugs Price (USD/MT) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. Novartis Heart Failure Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Pfizer Heart Failure Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. AstraZeneca Heart Failure Drugs Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Hikma Company Information
Table 86. Hikma Description and Business Overview
Table 87. Hikma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Hikma Heart Failure Drugs Product
Table 89. Hikma Recent Developments/Updates
Table 90. Teva Company Information
Table 91. Teva Description and Business Overview
Table 92. Teva Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Teva Heart Failure Drugs Product
Table 94. Teva Recent Developments/Updates
Table 95. Cipla Company Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Cipla Heart Failure Drugs Product
Table 99. Cipla Recent Developments/Updates
Table 100. Merck & Co. Company Information
Table 101. Merck & Co. Description and Business Overview
Table 102. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Merck & Co. Heart Failure Drugs Product
Table 104. Merck & Co. Recent Developments/Updates
Table 105. Amgen Company Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Amgen Heart Failure Drugs Product
Table 109. Amgen Recent Developments/Updates
Table 110. Roche Company Information
Table 111. Roche Description and Business Overview
Table 112. Roche Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Roche Heart Failure Drugs Product
Table 114. Roche Recent Developments/Updates
Table 115. Sun Pharma Company Information
Table 116. Sun Pharma Description and Business Overview
Table 117. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Sun Pharma Heart Failure Drugs Product
Table 119. Sun Pharma Recent Developments/Updates
Table 120. Mylan Company Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Mylan Heart Failure Drugs Product
Table 124. Mylan Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Heart Failure Drugs Distributors List
Table 128. Heart Failure Drugs Customers List
Table 129. Heart Failure Drugs Market Trends
Table 130. Heart Failure Drugs Market Drivers
Table 131. Heart Failure Drugs Market Challenges
Table 132. Heart Failure Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Heart Failure Drugs
Figure 2. Global Heart Failure Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Heart Failure Drugs Market Share by Type: 2024 & 2031
Figure 4. ACEI Product Picture
Figure 5. Angiotensin II Receptor Blockers Product Picture
Figure 6. ARNIs Product Picture
Figure 7. Beta Blockers Product Picture
Figure 8. Aldosterone Antagonists Product Picture
Figure 9. Diuretics Product Picture
Figure 10. Global Heart Failure Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Heart Failure Drugs Market Share by Application: 2024 & 2031
Figure 12. Reduced Ejection Fraction
Figure 13. Preserved Ejection Fraction
Figure 14. Global Heart Failure Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Heart Failure Drugs Market Size (2020-2031) & (US$ Million)
Figure 16. Global Heart Failure Drugs Sales (2020-2031) & (MT)
Figure 17. Global Heart Failure Drugs Average Price (USD/MT) & (2020-2031)
Figure 18. Heart Failure Drugs Report Years Considered
Figure 19. Heart Failure Drugs Sales Share by Manufacturers in 2024
Figure 20. Global Heart Failure Drugs Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Heart Failure Drugs Players: Market Share by Revenue in Heart Failure Drugs in 2024
Figure 22. Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Heart Failure Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 25. North America Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 29. Europe Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Heart Failure Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Heart Failure Drugs Revenue Market Share by Region (2020-2031)
Figure 37. China Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Taiwan Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 48. Latin America Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Heart Failure Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Heart Failure Drugs by Type (2020-2031)
Figure 58. Global Revenue Market Share of Heart Failure Drugs by Type (2020-2031)
Figure 59. Global Heart Failure Drugs Price (USD/MT) by Type (2020-2031)
Figure 60. Global Sales Market Share of Heart Failure Drugs by Application (2020-2031)
Figure 61. Global Revenue Market Share of Heart Failure Drugs by Application (2020-2031)
Figure 62. Global Heart Failure Drugs Price (USD/MT) by Application (2020-2031)
Figure 63. Heart Failure Drugs Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232